DEINOVE extends R&D deal with Flint Hills Resources with an eye to commercialization

May 31, 2017 |

In France, DEINOVE, a biotech company that discovers, develops and produces high-value compounds from rare bacteria, notably from the Deinococcus genus, announces the start of the second phase of the animal nutrition R&D project initiated with Flint Hills Resources in November 2015.

The project, initiated in 2015 and financed by Flint Hills Resources, aims to develop a nutritional supplement for animal feed. This first phase successfully selected several bacterial strains from DEINOVE’s library producing the targeted compounds. Scheduled to be completed by end of 2017 the second phase will aim to:

  • Produce the additives in sufficient quantities to test their beneficial effects on the target animal species and analyze the results obtained;
  • Optimize the fermentation parameters;
  • Define the technical and economic conditions for the development of the production process.

On the basis of efficacy tests, one or two strains may be selected for the industrialization step. If successful, both partners will consider the terms and conditions of a licensing agreement for the technology developed during this project for an actual commercialization.

Print Friendly, PDF & Email

Tags: ,

Category: Fuels

Thank you for visting the Digest.